Wire Stories
-
27.4KMITRE Australia Announces Collaborations with University Partners to Accelerate Innovation
New headquarters office in Canberra bridges government, industry, and academia to advance solutions to whole-of-nation challenges of national security and global significance...
-
26.6KVaxxas Appoints Doug Cubbin as Chief Financial Officer
CAMBRIDGE, Mass. & BRISBANE, Australia–(BUSINESS WIRE)–Vaxxas, a clinical-stage biotechnology company commercializing a novel vaccination platform, today announced another key addition to its...
-
28.9KThe Elephant Project Introduces �Baby Chaba� Stuffed Animal as the First of SaveUs� Collection to be Named After Its Real-World Counterpart
Founder Kristina McKean Continues to Donate 100% of Net Proceeds from All Toy Purchases to Rescue & Rehabilitation Efforts for the Real...
-
30.2KQurient Announces Dosing of First Patient in Q901 Phase 1/2 Clinical Study for the Treatment of Patients with Solid Tumors
SEOUL, South Korea–(BUSINESS WIRE)–#Qurient—Qurient Co. Ltd. (KRX: 115180), a clinical-stage biotech company based in Korea, today announced that the first patient has...
-
24.6KThe Elephant Project Introduces �Baby Chaba� Stuffed Animal as the First of SaveUs� Collection to be Named After Its Real-World Counterpart
Founder Kristina McKean Continues to Donate 100% of Net Proceeds from All Toy Purchases to Rescue & Rehabilitation Efforts for the Real...
-
27.5KThe Elephant Project Introduces �Baby Chaba� Stuffed Animal as the First of SaveUs� Collection to be Named After Its Real-World Counterpart
Founder Kristina McKean Continues to Donate 100% of Net Proceeds from All Toy Purchases to Rescue & Rehabilitation Efforts for the Real...
-
26.0KEmerson Chosen as Automation Partner for World�s Largest Hydrogen Refueling Station for Commercial Vehicles
Collaboration with KOHYGEN will help decarbonize transportation industry while expanding global hydrogen refueling infrastructure SEOUL, South Korea–(BUSINESS WIRE)–Korea Hydrogen Green Energy Network...
-
24.8KQurient Announces Dosing of First Patient in Q901 Phase 1/2 Clinical Study for the Treatment of Patients with Solid Tumors
SEOUL, South Korea–(BUSINESS WIRE)–#Qurient—Qurient Co. Ltd. (KRX: 115180), a clinical-stage biotech company based in Korea, today announced that the first patient has...
-
26.5KQurient Announces Dosing of First Patient in Q901 Phase 1/2 Clinical Study for the Treatment of Patients with Solid Tumors
SEOUL, South Korea–(BUSINESS WIRE)–#Qurient—Qurient Co. Ltd. (KRX: 115180), a clinical-stage biotech company based in Korea, today announced that the first patient has...
-
28.6KTransphorm Expands Footprint with GaN Application Lab in China
Greater China as New Location Increases Regional Capabilities for APAC Power Electronics Customers GOLETA, Calif.–(BUSINESS WIRE)–$TGAN #5G—Transphorm, Inc. (Nasdaq: TGAN)�a pioneer in...
To Top